Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ratto

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Human Gene Therapy|December 1, 1994
Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cellsJ H Kim, S Ratto, K V Sitz, et al.
Clinical and Experimental Immunology|May 1, 1997
Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1J H Kim, J E Loveland, K V Sitz, et al.
Neurology|March 18, 2009
HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort StudyV G Valcour, B T Shiramizu, P Sithinamsuwan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Comparison of HIV-1 envelope-specific CD4+ T cell lines simultaneously established from peripheral blood mononuclear cells and lymph node biopsy in HIV-1-infected individualsS Ratto-Kim, K V Sitz, A M Scherer, et al.
Neurology|September 15, 2004
Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairmentA Assini, S Cammarata, A Vitali, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infectionJ H Kim, J R Mascola, S Ratto-Kim, et al.
The Journal of Infectious Diseases|August 7, 1999
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infectionS Sei, S L Sandelli, G Theofan, et al.
Neurology|February 14, 2007
Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infectionV G Valcour, P Sithinamsuwan, S Nidhinandana, et al.
Vaccine|January 5, 2000
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health SciencesS Nitayaphan, C Khamboonruang, N Sirisophana, et al.
The Journal of Infectious Diseases|March 18, 2000
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine InvestigatorsD L Birx, L D Loomis-Price, N Aronson, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Human Gene Therapy|December 1, 1994
Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cellsJ H Kim, S Ratto, K V Sitz, et al.
Clinical and Experimental Immunology|May 1, 1997
Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1J H Kim, J E Loveland, K V Sitz, et al.
Neurology|March 18, 2009
HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort StudyV G Valcour, B T Shiramizu, P Sithinamsuwan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Comparison of HIV-1 envelope-specific CD4+ T cell lines simultaneously established from peripheral blood mononuclear cells and lymph node biopsy in HIV-1-infected individualsS Ratto-Kim, K V Sitz, A M Scherer, et al.
Neurology|September 15, 2004
Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairmentA Assini, S Cammarata, A Vitali, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infectionJ H Kim, J R Mascola, S Ratto-Kim, et al.
The Journal of Infectious Diseases|August 7, 1999
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infectionS Sei, S L Sandelli, G Theofan, et al.
Neurology|February 14, 2007
Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infectionV G Valcour, P Sithinamsuwan, S Nidhinandana, et al.
Vaccine|January 5, 2000
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health SciencesS Nitayaphan, C Khamboonruang, N Sirisophana, et al.
The Journal of Infectious Diseases|March 18, 2000
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine InvestigatorsD L Birx, L D Loomis-Price, N Aronson, et al.
Pageof 5